Venture Capital

Updated:

Inventages Venture Capital

Inventages Venture Capital is a London-based firm founded in 2000. It invests in life sciences, nutrition, and wellness sectors. The firm provides venture...

Inventages Venture Capital logo

Inventages Venture Capital

Inventages Venture Capital is a London-based firm founded in 2000. It invests in life sciences, nutrition, and wellness sectors. The firm provides venture capital funding and strategic support, along with connections to various companies and investment institutions.

General information

Firm type

Venture Capital

Year founded

1996

Location

Region

Latin America

Country

Bahamas

City

Nassau

Corporate office

Nassau, Bahamas

Principals

Gunnar Weikert

Chairman and Managing Partner

Sector focus

Digital HealthHealthcare ServicesAgriTech & FoodTech

Frequently asked questions

How is Inventages related to Nestlé Health Science, and what does that mean for portfolio companies?

Inventages operates as a venture-capital subsidiary within the Nestlé Health Science ecosystem. This affiliation gives portfolio companies potential access to Nestlé's global distribution network, clinical-research capabilities, and consumer-packaged-goods expertise. However, it also means Inventages functions less as an independent financial sponsor and more as a strategic corporate venture arm, which can shape target selection and holding periods.

Does Inventages participate in fund commitments or only direct deals?

Inventages primarily executes direct equity and minority co-investments in operating companies. There is no public record of the firm acting as a limited partner in third-party venture funds. Its model emphasizes board-level engagement and corporate-synergy capture rather than passive fund-of-funds exposure.

Which sectors does Inventages explicitly target?

Core sectors include digital health, personalized nutrition, microbiome therapeutics, metabolic-health platforms, and food-as-medicine interventions. The firm does not publicly list exclusions, but its deal history shows a focus on regulated, clinically validated products rather than general wellness or fitness-tech plays.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on venture capital firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Nassau Venture Capital profiles